http://www.youtube.com/watch?v=qu7ZpWecIS8
As you enjoy Clay Shirky's comments think of the application of "cognitive surplus" to health care in general, and specifically to drug development.
Only a very small fraction of the 1 trillion hours / year that are available for contribution is more than collective quantity of hours paid for by all the legacy drug developers. If you buy Clay's point - quality of contribution should be better which has to do with internal motivation vs. salary.
No comments:
Post a Comment